http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109433267-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5fdd9da231b319cb1307a50593392b9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2523-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-4283
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J35-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J37-086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-182
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-28
filingDate 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37fcb928a3d408b49685211c535ad123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a65385c8f0fd76c74a8537332739151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d073b4216923175433a1c42d9921063e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c2ff98aedb32433566d8f2cb6386af8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b9119672283cb8c409b1ce636cd9a6
publicationDate 2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109433267-A
titleOfInvention Preparation method of drug sputum intermediate for anti-delay hair movement disorder
abstract The invention belongs to the technical field of pharmacy, and in particular relates to a preparation method of a drug sputum intermediate for anti-delay dyskinesia. The invention adopts 2-methylimidazole and copper salt as raw materials to react in methanol, and then calcinifies to prepare a carbonized imidazole skeleton copper material, and then forms polyethylene with polyvinylpyrrolidone and surfactant cetyltrimethylammonium bromide. Pyrrolidone-coated carbonized imidazole skeleton copper porous crystal material; then polyvinylpyrrolidone coated carbonized imidazole skeleton copper porous crystal material is used as a catalyst for catalyzing the condensation of 5-chloropurine with p-bromofluorobenzene to prepare 5-chloro-1‐ (4-fluorophenyl)-1H-indole; the catalyst prepared by the invention has high catalytic efficiency, and the reaction can be balanced at 4-6 hours by using about 50 parts per thousand of the weight of 5-chloropurine, and the catalyst Can be recycled.
priorityDate 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015119887-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9859162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90187552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411523013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450766143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420014645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420010965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414871446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426173042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452322186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448366503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54263153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447595485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419596939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11171842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24593

Total number of triples: 74.